Paper4133950
Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.
Bubeník J and 5 others. Int J Cancer, 1973. Cited by 549 papers, by iCite.
Cite this record
ConductScience Library. Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Papers, record 4133950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4133950
- Cell line
- T24144 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Carcinoma | Major topic |
| Cell Line | Major topic |
| Urinary Bladder Neoplasms | Major topic |
| Animals | |
| Antigen-Antibody Reactions | |
| Cattle | |
| Cell Survival | |
| Cytoplasm | |
| Cytotoxicity Tests, Immunologic | |
| Epitopes | |
| Hematopoietic Stem Cells | |
| Humans | |
| Immune Sera | |
| Immunity, Cellular | |
| Inclusion Bodies | |
| Karyometry | |
| Leukocytes | |
| Mice | |
| Microscopy, Electron | |
| Osteosarcoma | |
| Staining and Labeling |
Source PubMed
Cited by159
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 549 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42231026 | An advanced in vitro bladder cancer model integrating bladder cancer spheroids into a healthy human urothelium for preclinical therapeutic testing. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42231026 | PubMed |
| 42095396 | Stage-Dependent Changes in Kynurenine Pathway Enzyme Expression Suggest Immune-Related Involvement in Bladder Cancer Progression. | Int J Urol | 2026 | https://conductscience.org/library/papers/42095396 | PubMed |
| 40509054 | Antitumor Effect of Curcumin, D6 Turmeric, and Hydrochloride Mitoxantrone on Canine and Human Urothelial Cancer Cells. | Animals (Basel) | 2025 | https://conductscience.org/library/papers/40509054 | PubMed |
| 40379622 | Cell populations simulated in silico within SimulCell accurately reproduce the behaviour of experimental cell cultures. | NPJ Syst Biol Appl | 2025 | https://conductscience.org/library/papers/40379622 | PubMed |
| 40170512 | Multidimensional OMICs reveal ARID1A orchestrated control of DNA damage, splicing, and cell cycle in normal-like and malignant urothelial cells. | Mol Oncol | 2025 | https://conductscience.org/library/papers/40170512 | PubMed |
| 39910105 | Amyloids in bladder cancer hijack cancer-related proteins and are positive correlated to tumor stage. | Sci Rep | 2025 | https://conductscience.org/library/papers/39910105 | PubMed |
| 39512531 | Downregulation of the keratins CK13 and CK14 does not significantly affect cell viability of human urinary bladder carcinoma cells. | Contemp Oncol (Pozn) | 2024 | https://conductscience.org/library/papers/39512531 | PubMed |
| 38339062 | Transcriptome Analysis Reveals Anti-Cancer Effects of Isorhapontigenin (ISO) on Highly Invasive Human T24 Bladder Cancer Cells. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38339062 | PubMed |
| 37318278 | Genetic Engineering of Bacteriophage K1F with Human Epidermal Growth Factor to Enhance Killing of Intracellular E. coli K1. | ACS Synth Biol | 2023 | https://conductscience.org/library/papers/37318278 | PubMed |
| 37090731 | Downregulated ESRP1/2 promotes lung metastasis of bladder carcinoma through altering FGFR2 splicing and macrophage polarization. | Front Immunol | 2023 | https://conductscience.org/library/papers/37090731 | PubMed |
| 36672707 | New Nitric Oxide-Releasing Compounds as Promising Anti-Bladder Cancer Drugs. | Biomedicines | 2023 | https://conductscience.org/library/papers/36672707 | PubMed |
| 36439552 | Targeting Bladder Urothelial Carcinoma with pHLIP-ICG and Inhibition of Urothelial Cancer Cell Proliferation by pHLIP-amanitin. | Front Urol | 2022 | https://conductscience.org/library/papers/36439552 | PubMed |
| 36428758 | Higher Expression of Annexin A2 in Metastatic Bladder Urothelial Carcinoma Promotes Migration and Invasion. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36428758 | PubMed |
| 36293346 | Response of the Urothelial Carcinoma Cell Lines to Cisplatin. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36293346 | PubMed |
| 36011004 | Bisphenols A and S Alter the Bioenergetics and Behaviours of Normal Urothelial and Bladder Cancer Cells. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36011004 | PubMed |
| 35917375 | A three component model for superdiffusive motion effectively describes migration of eukaryotic cells moving freely or under a directional stimulus. | PLoS One | 2022 | https://conductscience.org/library/papers/35917375 | PubMed |
| 35336366 | Force Sensing on Cells and Tissues by Atomic Force Microscopy. | Sensors (Basel) | 2022 | https://conductscience.org/library/papers/35336366 | PubMed |
| 35109796 | Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35109796 | PubMed |
| 34938855 | Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance. | Mol Ther Oncolytics | 2021 | https://conductscience.org/library/papers/34938855 | PubMed |
| 34890578 | Disentangling cadherin-mediated cell-cell interactions in collective cancer cell migration. | Biophys J | 2022 | https://conductscience.org/library/papers/34890578 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4133950
GET https://conductscience.org/api/papers/v1/4133950/cited_by?page=2